Is E-cadherin a useful surrogate marker to predict chemosensitivity of chemotherapy for triple-negative breast cancer?

被引：1
|
作者：
Kashiwagi, S. [1 ]
Yashiro, M. [1 ]
Takashima, T. [1 ]
Aomatsu, N. [1 ]
Kawajiri, H. [1 ]
Onoda, N. [1 ]
Nakata, B. [1 ]
Ishikawa, T. [1 ]
Hirakawa, K. [1 ]
机构：
[1] Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka 558, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.1077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1077
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancer
    Drobniene, Monika
    Breimelyte, Dominyka
    Sadzeviciene, Ieva
    Sabaliauskaite, Rasa
    Valkiuniene, Ruta Barbora
    Meskauskas, Raimundas
    Dabkeviciene, Daiva
    Jarmalaite, Sonata
    BREAST, 2025, 80
  • [42] Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer
    Inayatullah, Mohammed
    Mahesh, Arun
    Turnbull, Arran K.
    Dixon, J. Michael
    Natrajan, Rachael
    Tiwari, Vijay K.
    EMBO MOLECULAR MEDICINE, 2024, 16 (04) : 823 - 853
  • [43] EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer
    Nogi, Hiroko
    Kobayashi, Tadashi
    Suzuki, Masafumi
    Tabei, Isao
    Kawase, Kazumi
    Toriumi, Yasuo
    Fukushima, Hisaki
    Uchida, Ken
    ONCOLOGY REPORTS, 2009, 21 (02) : 413 - 417
  • [44] PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim
    Jessica H. Byerly
    Elisa R. Port
    Hanna Y. Irie
    Breast Cancer Research, 22
  • [45] PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim
    Byerly, Jessica H.
    Port, Elisa R.
    Irie, Hanna Y.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [46] Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
    Moffa, Giuliana
    Galati, Francesca
    Collalunga, Emmanuel
    Rizzo, Veronica
    Kripa, Endi
    D'Amati, Giulia
    Pediconi, Federica
    DIAGNOSTICS, 2020, 10 (12)
  • [47] Tumor Microenvironment Can Predict Chemotherapy Response of Patients with Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
    Kim, Dongjin
    Yu, Yeuni
    Jung, Ki Sun
    Kim, Yun Hak
    Kim, Jae-Joon
    CANCER RESEARCH AND TREATMENT, 2024, 56 (01): : 162 - 177
  • [48] Platinum-based chemotherapy in triple-negative breast cancer
    Sirohi, B.
    Arnedos, M.
    Popat, S.
    Ashley, S.
    Nerurkar, A.
    Walsh, G.
    Johnston, S.
    Smith, I. E.
    ANNALS OF ONCOLOGY, 2008, 19 (11) : 1847 - 1852
  • [49] Platinum-Based Chemotherapy in Triple-Negative Breast Cancer
    Villarreal-Garza, C.
    Bouganim, N.
    Khalaf, D.
    Clemons, M.
    Kassam, F.
    Enright, K.
    Verma, S.
    Myers, J.
    Dent, R.
    CANCER RESEARCH, 2011, 71
  • [50] Chlorin Conjugates in Photodynamic Chemotherapy for Triple-Negative Breast Cancer
    Isaac-Lam, Meden F.
    PHARMACEUTICALS, 2024, 17 (05)
12345